Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2261.1%
Neutral1336.1%
Bearish12.8%
FN2 Earnings Intelligence
Nasdaq, Inc. analyst ratings
Nasdaq, Inc. (NDAQ) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$95.55Current
$55Low
$86.49Average
$120High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Jul 24, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 10, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 30, 2026 |
| UBS | Buy | Buy | Maintain | Jan 12, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 25, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 15, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 2, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 8, 2025 |
| B of A Securities | Buy | Buy | Maintain | Apr 2, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 5, 2024 |
| Rosenblatt | Neutral | Buy | Downgrade | May 8, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 30, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 14, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Aug 19, 2022 |
| Loop Capital | Buy | Buy | Maintain | Oct 9, 2020 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 10, 2020 |
| Compass Point | Neutral | Neutral | Maintain | Apr 6, 2020 |
| Bernstein | Perform | Market Perform | Maintain | Apr 10, 2018 |
| Bank of America | Underperform | Underperform | Maintain | Feb 1, 2018 |
| Jefferies | Hold | Hold | Maintain | Jul 17, 2017 |
| CLSA | Buy | Outperform | Maintain | Dec 5, 2016 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 28, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | May 20, 2016 |
| Buckingham Research | Buy | Buy | Maintain | Apr 27, 2016 |
| Portales Partners | Sector Perform | Outperform | Downgrade | Apr 24, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Jul 14, 2014 |
| Evercore ISI Group | Overweight | Equal Weight | Upgrade | Jul 14, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Feb 12, 2013 |
| Stifel | Buy | Buy | Maintain | Jan 15, 2013 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 13, 2012 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $95.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Michael Cyprys | $120 | $91.56 | +25.6% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $111 | $90.42 | +16.2% | Jul 24, 2026 |
| Morgan Stanley | Analyst unavailable | $112 | $88.81 | +17.2% | Jul 10, 2026 |
| Raymond James | Patrick O'Shaughnessy | $113 | $86.1 | +18.3% | Jul 9, 2026 |
| Redburn Partners | Simon Clinch | $110 | $86.72 | +15.1% | Jun 11, 2026 |
| Loop Capital Markets | Analyst unavailable | $113 | $87.04 | +18.3% | Apr 24, 2026 |
| Raymond James | Patrick O\'Shaughnessy | $109 | $83.99 | +14.1% | Feb 25, 2026 |
| Morgan Stanley | Michael Cyprys | $116 | $98.42 | +21.4% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $113 | $100.91 | +18.3% | Jan 15, 2026 |
| UBS | Alex Kramm | $120 | $99.37 | +25.6% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $115 | $100.4 | +20.4% | Jan 8, 2026 |
| Morgan Stanley | Analyst unavailable | $111 | $95.36 | +16.2% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $114 | $93.86 | +19.3% | Dec 12, 2025 |
| Morgan Stanley | Analyst unavailable | $110 | $86.02 | +15.1% | Nov 20, 2025 |
| Barclays | Benjamin Budish | $109 | $90.33 | +14.1% | Oct 22, 2025 |
| Raymond James | Patrick O'Shaughnessy | $100 | $88.9 | +4.7% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $108 | $90.14 | +13.0% | Oct 9, 2025 |
| Barclays | Benjamin Budish | $108 | $88.44 | +13.0% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $90 | $87.1 | -5.8% | Oct 1, 2025 |
| Raymond James | Patrick O'Shaughnessy | $96 | $89.58 | +0.5% | Jul 9, 2025 |
| Oppenheimer | Owen Lau | $96 | $85.95 | +0.5% | Jun 17, 2025 |
| Raymond James | Patrick O'Shaughnessy | $84 | $76.36 | -12.1% | Jan 9, 2025 |
| Raymond James | Patrick O'Shaughnessy | $82 | $71.62 | -14.2% | Oct 14, 2024 |
| RBC Capital | Ashish Sabadra | $88 | $72.56 | -7.9% | Sep 26, 2024 |
| Morgan Stanley | Joseph Moore | $55 | $73.51 | -42.4% | Sep 4, 2024 |
| Bank of America Securities | Craig Siegenthaler | $90 | $71.39 | -5.8% | Sep 4, 2024 |
| Oppenheimer | Owen Lau | $78 | $69.15 | -18.4% | Jul 30, 2024 |
| Argus Research | Kevin Heal | $66 | $60.62 | -30.9% | May 14, 2024 |
| Oppenheimer | Owen Lau | $72 | $63.06 | -24.6% | Apr 12, 2024 |
| Barclays | Benjamin Budish | $76 | $63.01 | -20.5% | Apr 11, 2024 |
| Morgan Stanley | Michael Cyprys | $80 | $62.14 | -16.3% | Apr 9, 2024 |
| Deutsche Bank | Brian Bedell | $60 | $61.06 | -37.2% | Apr 5, 2024 |
| Goldman Sachs | Alexander Blostein | $73 | $61.06 | -23.6% | Mar 26, 2024 |
| Rosenblatt Securities | Andrew Bond | $82 | $51.29 | -14.2% | Oct 19, 2023 |
| Oppenheimer | Owen Lau | $65 | $51.02 | -32.0% | Jun 13, 2023 |
| Morgan Stanley | Michael Cyprys | $60 | $54.52 | -37.2% | Apr 11, 2023 |
| Credit Suisse | Gautam Sawant | $57 | $62.35 | -40.3% | Nov 2, 2022 |
| Deutsche Bank | Brian Bedell | $61.33 | $48.71 | -35.8% | May 23, 2022 |
| Deutsche Bank | Brian Bedell | $69 | $54.59 | -27.8% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $79.67 | $57.47 | -16.6% | Apr 21, 2022 |
| Rosenblatt Securities | Analyst unavailable | $68 | $57.6 | -28.8% | Apr 21, 2022 |
| Rosenblatt Securities | Sean Horgan | $66.67 | $55.49 | -30.2% | Mar 10, 2022 |
| Deutsche Bank | Brian Bedell | $70 | $57.18 | -26.7% | Feb 21, 2022 |
| Deutsche Bank | Brian Bedell | $79 | $62.05 | -17.3% | Jan 17, 2022 |
| Jefferies | Daniel Fannon | $63 | $62.84 | -34.1% | Jan 10, 2022 |
| Goldman Sachs | Alexander Blostein | $63.33 | $67.27 | -33.7% | Jan 3, 2022 |
| Piper Sandler | Richard Repetto | $73.33 | $67.85 | -23.3% | Dec 22, 2021 |
| Atlantic Equities | Simon Clinch | $73.33 | $64.8 | -23.3% | Sep 14, 2021 |
| Compass Point | Christopher Allen | $65 | $61.25 | -32.0% | Jul 22, 2021 |
| Barclays | Jeremy Campbell | $58.33 | $52.61 | -38.9% | Apr 22, 2021 |
| Wells Fargo | Christopher Harris | $62 | $52.61 | -35.1% | Apr 22, 2021 |
Track every rating change on NDAQ the moment it posts. Free to start.
Start free